PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France
Abstract
Authors
L. Chiche F. Lefrere M. Chulikavit A. Perrin L. Stern M. Bischof S. Cohen